MedPath

HERCEPTIN SC

HERCEPTIN SC

Approved
DIN Number

02480697

Drug Class

Human

Market Date

Oct 12, 2018

Company
HC

Hoffmann-La Roche Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02480697
AIG Number0154252003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
L01FD01 TRASTUZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TRASTUZUMABActive
Strength: 600 MG / 5 ML
Monograph: TRASTUZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.